Dee Sparacio
@womenofteal.bsky.social
📤 1098
📥 330
📝 69
Ovarian Cancer Survivor , cancer research advocate,
#GYNCSM
community cofounder , blogger
Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement - Gynecologic Oncology
www.gynecologiconcology-online.net/article/S009...
#gyncsm
loading . . .
Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement
Gynecologic malignancies accounted for ∼15 % of new cancer cases and cancer survivors in 2022. Advances in cancer care are expected to improve outcomes, and the growth in survivorship is expected to i...
https://www.gynecologiconcology-online.net/article/S0090-8258%2825%2901098-4/fulltext
13 days ago
0
0
0
I said goodbye to my best friend, Amber, yesterday. She was my best survivorship therapy.
#gyncsm
womenofteal.blogspot.com/2026/01/beyo...
loading . . .
https://womenofteal.blogspot.com/2026/01/beyond
21 days ago
0
0
0
Research Study for the Genetics of Breast Cancer - Open now led by Dr. Tara Matise (
@facingourrisk.bsky.social
and Rutgers University) Rutgers Genetics Coordinating Center
bcstudy.org/FORCE
Open in the US to 18yrs +, having had cancer or not, with Internet access.
#gyncsm
#bcsm
#lcsm
loading . . .
Join Our Remote Breast Cancer Study
Participate in a groundbreaking study to advance breast cancer treatment. Receive a genetic ancestry report. Open to US residents 18+.
https://bcstudy.org/FORCE
26 days ago
0
3
1
about 2 months ago
0
1
0
I've been remiss at posting on my blog for the past two months. All is good just busy with normal things in life. Got back to it with this post Finding our Waze - How has your experience with cancer changed through the years?
womenofteal.blogspot.com/2025/12/find...
loading . . .
Finding our WAZE
I haven't written a blog post in quite some time. It seems that life got in the way of my writing. Then, once I had time, I couldn't seem t...
https://womenofteal.blogspot.com/2025/12/finding-our-waze.html
2 months ago
0
2
0
reposted by
Dee Sparacio
@doublewhammied
3 months ago
"Findings demonstrate
#ctDNA
is a promising biomarker 2 complement existng monitorng approachs 4 recurrent
#ovariancancer
, in some cases capable of predictng relapse & treatmnt response ahead of currnt clinical indicators. Identified discordances underscore ..." 1/2
#CanSky
@womenofteal.bsky.social
loading . . .
Dynamic Monitoring of Recurrent Ovarian Cancer Using Serial ctDNA: A Real-World Case Series - PubMed
Recurrent ovarian cancer (OC) is challenging to detect early using current methods like CA-125 and imaging. Circulating tumor DNA (ctDNA) may improve disease monitoring. Here, we assess the real-world clinical utility of serial ctDNA analyses in patients with recurrent OC. We analyzed serial plasma …
https://pubmed.ncbi.nlm.nih.gov/41149505/
1
3
1
reposted by
Dee Sparacio
The Kuni Foundation
8 months ago
🎧🧬🎙️ Listen to Dr. Mary (Nora) Disis from
@uwcvi.bsky.social
where she discusses groundbreaking research on cancer prevention through vaccines & more. Many thanks to Dr. Disis & the UW CVI team for your visionary work!
#CancerResearch
#SupportScience
#CancerPrevention
#WomenInScience
#Philanthropy
loading . . .
Are Cancer Vaccines the Breakthrough We’ve Been Waiting For?
YouTube video by Outperform Cancer with Marybeth Gilliam
https://www.youtube.com/watch?v=XmgmiLYATGQ
0
3
2
reposted by
Dee Sparacio
Cancer Vaccine Institute (CVI) at UW Medicine
7 months ago
At the CVI, Adam Prince works with over 30,000 frozen blood samples, some dating to the 1980s. Stored in liquid nitrogen, this living archive reveals how the immune system responds to our cancer vaccines, even decades later. Meet Adam
#OnTheCancerResearchFrontier
:
www.uwcvi.org/post/on-the-...
0
3
2
reposted by
Dee Sparacio
Cancer Vaccine Institute (CVI) at UW Medicine
5 months ago
🩵 September is
#OvarianCancer
Awareness Month. One of the deadliest gynecologic cancers saw its federal research funding slashed from $45M to $15M. Cancer vaccine breakthroughs are near—but progress may stall. 📢 RT to amplify.
#OvarianCancer
0
2
1
reposted by
Dee Sparacio
Cancer Vaccine Institute (CVI) at UW Medicine
5 months ago
🧬 Ovarian cancer is one of the deadliest gynecologic cancers—but breakthroughs are finally within reach. At the UW CVI, 4 promising vaccines are advancing toward a future of prevention & lasting treatment. Hope is no longer hypothetical. It’s happening.
tinyurl.com/42xa6ya4
0
2
1
Latest blog post for
#GCAM
Diagnosis, stages and types
womenofteal.blogspot.com/2025/09/gcam...
#gyncsm
loading . . .
#GCAM Diagnosis and Types and Stages of Ovarian Cancer
I spoke about how there are symptoms of ovarian cancer( gloating, freq urination etc) in my previous post. What happens when you go to your ...
https://womenofteal.blogspot.com/2025/09/gcam-diagnosis-and-types-and-stages-of.html
5 months ago
0
3
1
It is
#GCAM
so I will be sharing info via blog posts. Here is the latest about Symptoms of Ovarian Cancer.
womenofteal.blogspot.com/2025/09/gcam...
#gyncsm
Thanks @GYNCancer for the graphic.
#ASKHER
#ASKME
loading . . .
#GCAM Symptoms of Ovarian Cancer
I follow the Foundation for Women's Cancer and loved the design of this graphic for #GCAM. I would change the hashtag #ASKHER to #ASKME. ...
https://womenofteal.blogspot.com/2025/09/gcam-symptoms-of-ovarian-cancer.html
5 months ago
0
2
0
It's Sept 1st - Ovarian Cancer Awareness Month/ Gyn Cancer Awareness Month My latest blog post
womenofteal.blogspot.com/2025/09/sept...
will start the sharing of info. What will you do this month to raise awareness and funds for research?
#gyncsm
#OCAM
#GCAM
loading . . .
September is OVARIAN CANCER AWARENESS MONTH
I am not sure where the month of August went and here we are starting September. If you have followed me for any period of time you are prob...
https://womenofteal.blogspot.com/2025/09/september-is-ovarian-cancer-awareness.html
5 months ago
0
1
0
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities url:
aacrjournals.org/clincancerre...
#gyncsm
Half the women in clinical remission showed assessable min residual disease via SLL or ctDNA
loading . . .
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities
AbstractPurpose:. Minimal residual disease (MRD) after first-line treatment of advanced-stage ovarian cancer remains a long-standing barrier to cure. We investigated the prognostic and translational v...
https://aacrjournals.org/clincancerres/article/doi/10.1158/1078-0432.CCR-25-0512/764351/Surgical-and-Blood-Based-Minimal-Residual-Disease
5 months ago
0
0
0
New Global Guidelines for Treating Gestational Trophoblastic Diseases
www.medpagetoday.com/reading-room...
loading . . .
New Global Guidelines for Treating Gestational Trophoblastic Diseases
Consensus document from four international groups
https://www.medpagetoday.com/reading-room/asco/gynecological-cancers/116849
6 months ago
0
1
0
New Global Guidelines for Treating Gestational Trophoblastic Diseases
www.medpagetoday.com/reading-room...
#gyncsm
loading . . .
New Global Guidelines for Treating Gestational Trophoblastic Diseases
Consensus document from four international groups
https://www.medpagetoday.com/reading-room/asco/gynecological-cancers/116849
6 months ago
0
1
0
Grateful to be celebrating 20 years since my diagnosis with stage 3b HGSOC.
womenofteal.blogspot.com/2025/07/gratef
loading . . .
https://womenofteal.blogspot.com/2025/07/gratef
6 months ago
2
2
0
More Precise Treatments for Rare Uterine Tumors
www.medpagetoday.com/reading-room...
#gyncsm
loading . . .
More Precise Treatments for Rare Uterine Tumors
Advances in biological and molecular understanding of these diseases have made a difference
https://www.medpagetoday.com/reading-room/asco/gynecological-cancers/116405
7 months ago
0
0
0
reposted by
Dee Sparacio
OncLive
7 months ago
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer
#oncology
#EndometrialCancer
www.onclive.com/view/dostarl...
loading . . .
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer
After 3 years of follow-up, dostarlimab plus chemotherapy was effective and tolerable in patients aged 70 years or older with endometrial cancer.
https://www.onclive.com/view/dostarlimab-plus-chemo-prolongs-time-to-first-second-subsequent-therapy-regardless-of-age-in-endometrial-cancer
0
0
1
reposted by
Dee Sparacio
OncoDaily
7 months ago
Empowering Oncologists: Who speaks up for patients far from the center?
oncodaily.com/dialogues/32...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
#EmpoweringOncologists
loading . . .
Empowering Oncologists: Who speaks up for patients far from the center? - OncoDaily
Empowering Oncologists: Who speaks up for patients far from the center? / cancer, Dr. Jasmine Kamboj, Dr. Wade Swenson, Empowering Oncologists, OncoDaily,
https://oncodaily.com/dialogues/327346
0
7
1
reposted by
Dee Sparacio
Lisa MG, RN
7 months ago
Upfront Radical Cytoreductive Surgery Extends Progression-Free Survival in Advanced
#OvarianCancer
@ascopost.bsky.social
#gyncsm
#womenshealth
#cancerresearch
#medsky
loading . . .
Upfront Radical Cytoreductive Surgery Extends Progression-Free Survival in Advanced Ovarian Cancer
The TRUST trial is the first phase III randomized study to show improved progression-free survival for primary cytoreductive surgery compared with interval surgery without compromising short-term or l...
https://ascopost.com/news/july-2025/upfront-radical-cytoreductive-surgery-extends-progression-free-survival-in-advanced-ovarian-cancer/?utm_source=ONC-TAP-EN-071125
0
2
1
reposted by
Dee Sparacio
Dr. Emily Drake
7 months ago
⏰Tune in this Tuesday (15th) for the next
#AYACSM
(
#AYACancer
societal movement)
#SkyChat
here on
@bsky.app
👋 Everyone who works in the
#AYACancer
field and/or who has lived experience is welcome!
#OncSky
#TYACancer
@scottcapozza.bsky.social
@maryamlustberg.bsky.social
@darcyburbage.bsky.social
1
7
7
Pls share NJ Cancer survivors/caregivers: Members of the NJ Cancer Control Survivorship Workgroup want to understand the everyday needs of cancer survivors in New Jersey. Help us plan future programs by completing this anonymous survey.
healthsurveys.nj.gov/NoviSurvey/n/z
8 months ago
0
3
1
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Today we share some quotes/ advice
accorg.bsky.social
cr4h.bsky.social
elixirfund.bsky.social
8 months ago
0
3
1
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Part of our work includes raising awareness around cancer survivorship.
@accorg.bsky.social
@cr4h.bsky.social
@elixirfund.bsky.social
8 months ago
0
2
1
Here's a look at some of the interesting research from
#ASCO2025
.
womenofteal.blogspot.com/2025/06/look...
#gyncsm
loading . . .
Looking Back at #ASCO2025 Research
It has been a busy June for me with family and personal commitments. I was able to attend the ASCO annual meeting virtually and have picked ...
https://womenofteal.blogspot.com/2025/06/looking-back-at-asco2025-research.html
8 months ago
0
2
0
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Part of our work includes raising awareness around cancer survivorship.
@accorg.bsky.social
@cr4h.bsky.social
@elixirfund.bsky.social
8 months ago
0
1
0
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Part of our work includes raising awareness around cancer survivorship.
@accorg.bsky.social
@cr4h.bsky.social
@elixirfund.bsky.social
8 months ago
0
1
1
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Part of our work includes raising awareness around cancer survivorship.
@accorg.bsky.social
@cr4h.bsky.social
@elixirfund.bsky.social
8 months ago
0
2
1
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Part of our work includes raising awareness around cancer survivorship.
@accorg.bsky.social
@cr4h.bsky.social
@elixirfund.bsky.social
8 months ago
0
2
1
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Part of our work includes raising awareness around cancer survivorship.
@accorg.bsky.social
@cr4h.bsky.social
@elixirfund.bsky.social
8 months ago
0
1
1
I can't attend
#ASCO25
in person this year but I did register for patient advocate virtual access. I hope to view some the the presentations live and will do some on-demand. For those attending in person the gyn or survivorship sessions -please use the
#gyncsm
hashtag. Thanks.
8 months ago
0
1
0
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer | Journal of Clinical Oncology
ascopubs.org/doi/10.1200/...
#gyncsm
loading . . .
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
From 2014 through 2019, the US Food and Drug Administration (FDA) granted approval to six indications for poly (ADP-ribose) polymerase (PARP) inhibitors in advanced epithelial ovarian cancer (EOC). Fr...
https://ascopubs.org/doi/10.1200/JCO-24-02834
8 months ago
0
0
0
reposted by
Dee Sparacio
Dr Joseph McCollom DO
9 months ago
Just in time for
#ASCO25
⏰ Honored to be a part of this outstanding effort! Lead by dear colleagues
@crisbergerot.bsky.social
and
@billyrosaphd.bsky.social
#pallonc
access in
#LMICs
🌎 is limited;
@ascocancer.bsky.social
guideline varies due to 🔑 systemic barriers. 🔗:
ascopubs.org/doi/pdfdirec...
add a skeleton here at some point
2
10
4
#gyncsm
check out this opportunity, THE PITCH! a contest for gyn cancer projects to improve access to care, information and support, treatment, clinical trials, and/or research by addressing equity and equality issues. Apply by MAY 23. 1/2
9 months ago
1
0
0
reposted by
Dee Sparacio
Usha Lee McFarling
10 months ago
The result below. My tireless colleagues are so amazing.
@mmolteni.bsky.social
@jonathanwosen.bsky.social
@jaspar.bsky.social
www.statnews.com/2025/04/24/t...
loading . . .
NIH grants plummeted $2.3 billion in Trump’s first months, as federal-academia partnership crumbles
The NIH has scaled back its awards of new grants by at least $2.3 billion since the beginning of the year, a STAT analysis shows.
https://www.statnews.com/2025/04/24/trump-100-days-nih-new-grants-cut/
1
16
7
I review research that caught my eye in my latest blog post.
womenofteal.blogspot.com/2025/04/canc...
#gyncsm
Dormant cancer cells and mesenchymal stem cells (MSCs) that may cause STICs to develop into ovarian cancer cells
loading . . .
Cancer Research That Caught my Eye
Two emails, I received from the NCI this week contained studies that caught my eye. Aged and BRCA mutated stromal cells drive epithelial c...
https://womenofteal.blogspot.com/2025/04/cancer-research-that-caught-my-eye.html
10 months ago
0
1
0
What’s at the Root of Ovarian Cancer? New Study May Have Found Part of the Answer From the NCI
www.cancer.gov/news-events/...
mesenchymal stem cells (MSCs) may play a role when STIC lesions from the fallopian tubes develop into HGSOC
#gyncsm
loading . . .
Study Pinpoints Potential Ovarian Cancer Driver
A type of stem cell appears to fuel the formation of cancerous lesions in the fallopian tubes and the lesions’ transition to ovarian cancer, a new study shows.
https://www.cancer.gov/news-events/cancer-currents-blog/2025/ovarian-cancer-stic-high-risk-mscs?cid=eb_govdel
10 months ago
0
0
0
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma
www.medpagetoday.com/reading-room...
#gyncsm
loading . . .
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma
An ASCO Reading Room selection
https://www.medpagetoday.com/reading-room/asco/gynecological-cancers/115014
10 months ago
0
0
0
reposted by
Dee Sparacio
Scott McGrath
10 months ago
Tagging for 🧪 🩺 🛟
add a skeleton here at some point
0
18
11
reposted by
Dee Sparacio
Lisa MG, RN
10 months ago
Prevalence of
#GeneticTesting
in Women With
#OvarianCancer
: Investigators have found that nearly 50% of women diagnosed with ovca may not be receiving testing that could help guide their treatment. Via
@ascopost.bsky.social
#gyncsm
#hereditarycancer
#womenshealth
#BRCA
#cancerresearch
#medsky
loading . . .
Prevalence of Genetic Testing in Women With Ovarian Cancer
Investigators have found that a concerningly low proportion of women diagnosed with ovarian cancer may be receiving the genetic testing that could help guide their treatment and potentially improve ou...
https://ascopost.com/news/march-2025/prevalence-of-genetic-testing-in-women-with-ovarian-cancer
0
6
3
reposted by
Dee Sparacio
Tumori Journal - TJ
11 months ago
Dr. Giorgio Bogani presents their article
#HPV
-related lesions after
#hysterectomy
for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer 👉A focus on the potential role of
#vaccination
youtu.be/YSaIGH2zMR8
#GYNCSM
#CanSky
#OncSky
loading . . .
Adoption of HPV vaccination in patients having treatment for HPV-related disease
HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of va...
https://youtu.be/YSaIGH2zMR8
0
2
1
reposted by
Dee Sparacio
OncLive
10 months ago
Relacorilant Plus Nab-Paclitaxel Improves Survival in Platinum-Resistant Ovarian Cancer
#gyncsm
#oncology
#MedEd
www.onclive.com/view/relacor...
loading . . .
Relacorilant Plus Nab-Paclitaxel Improves Survival in Platinum-Resistant Ovarian Cancer
Relacorilant plus nab-paclitaxel demonstrated improved PFS and OS in platinum-resistant ovarian cancer.
https://www.onclive.com/view/relacorilant-plus-nab-paclitaxel-improves-survival-in-platinum-resistant-ovarian-cancer
0
3
2
AI shows how drugs affect ovarian cancer cells
medicalxpress.com/news/2025-03...
via
@medicalxpress.com.web.brid.gy
Thanks Robin
@smartpatients.bsky.social
for sharing this information .
#gyncsm
loading . . .
AI shows how drugs affect ovarian cancer cells
In a study on ovarian cancer cells, researchers from Karolinska Institutet demonstrate how the tumor environment influences how cancer cells respond to drugs by using AI. The study has been published ...
https://medicalxpress.com/news/2025-03-ai-drugs-affect-ovarian-cancer.html
10 months ago
0
2
1
reposted by
Dee Sparacio
OpenNotes
11 months ago
It's
#PatientSafetyAwarenessWeek
! We are lucky to have Sigall Bell, MD as the Director of Patient Safety and Discovery at
#OpenNotes
. Have a look at our Patient Safety Toolkit to learn more about the outcome of her important work:
lnkd.in/eb8P_Hej
www.opennotes.org/patient-safe...
#medsky
loading . . .
Patient Safety & Open Notes - Open Notes
Open notes are an important tool for improving patient safety.
https://www.opennotes.org/patient-safety-toolkit/
0
2
1
Attending the
#SGOMtg
this year? Please help
#MultiplyYourImpact
by sharing news from the meeting using the
#gyncsm
hashtag. Thanks!
11 months ago
0
4
1
reposted by
Dee Sparacio
Lurie Cancer Center
12 months ago
Recent advances have shown the benefits of adding
#immunotherapy
to chemotherapy, and established that strategy as the standard of care for patients with
#endometrialcancer
, says Emily Hinchcliff, MD of
@luriecancer.bsky.social
www.onclive.com/view/dr-hinc...
via
@onclive.bsky.social
#GYNCSM
#oncsky
loading . . .
Dr Hinchcliff on the Benefits of Chemoimmunotherapy in Endometrial Cancer
Emily M. Hinchcliff, MD, MPH, discusses how the addition of immunotherapy to chemotherapy has influenced the endometrial cancer treatment paradigm.
https://www.onclive.com/view/dr-hinchcliff-on-the-benefits-of-chemoimmunotherapy-in-endometrial-cancer
0
3
4
reposted by
Dee Sparacio
Renaud Sabatier
11 months ago
Practical clinical management of ocular adverse events related to Anti...
sciencedirect.com/science/articl…
Take a look at our latest review about ocular toxicities o
#ADCs
Cs i
#gyncsm
s
m @paoli-calmettes.bsky.soci
a
l @crcm.bsky.soci
al
@oncoalert.bsky.soci
al !
loading . . .
https://sciencedirect.com/science/articl…
0
1
1
reposted by
Dee Sparacio
OncLive
11 months ago
Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer
#gyncsm
#MedEd
www.onclive.com/view/immunot...
loading . . .
Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer
Matthew Wagar, MD, discusses treatment considerations for advanced/recurrent endometrial cancer.
https://www.onclive.com/view/immunotherapy-continues-to-redefine-treamtent-considerations-in-advanced-recurrent-endometrial-cancer
0
1
1
reposted by
Dee Sparacio
Lisa MG, RN
11 months ago
A family tree gene revelation may have saved my life: This led to the 34-year-old having
#genetictesting
and finding out she has a faulty
#BRCA
gene mutation. A number of women on her paternal side had died from breast cancer at young ages.
#hereditarycancer
#bcsm
#gyncsm
#womenshealth
loading . . .
A family tree BRCA gene revelation may have saved my life
Hannah Howie was a year away from getting married when a revelation from the past turned her life upside down.
https://www.bbc.com/news/articles/cgl0zzj299jo
0
6
2
Load more
feeds!
log in
